Inventor · disambiguated record
Neil W. Johnson
Also filed as: JOHNSON NEIL · JOHNSON NEIL W
21 granted patents·14 pending applications·172 citations·filing 2000–2024
95Inventor score
Files withGLAXOSMITHKLINE LLC9SMITHKLINE BEECHAM CORP6QUANTA THERAPEUTICS INC4ADAMS JERRY LEROY3GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD3
Top patents by PatentIndex Score
35 records- 0193US8853408B2Cyclopropylamines as LSD1 inhibitorsJOHNSON NEIL W·Filed 2012·Granted Oct 7, 2014·40 cites·4 claims
- 0290US8415345B2Benzene sulfonamide thiazole and oxazole compoundsADJABENG GEORGE·Filed 2009·Granted Apr 9, 2013·26 cites·14 claims
- 0389US8975291B2IndolesGLAXOSMITHKLINE LLC·Filed 2013·Granted Mar 10, 2015·12 cites·5 claims
- 0488US9505745B2Enhancer of zeste homolog 2 inhibitorsGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2014·Granted Nov 29, 2016·11 cites·20 claims
- 0588US7625903B2Anthranilamide inhibitors of Aurora kinaseSMITHKLINE BEECHAM CORP·Filed 2008·Granted Dec 1, 2009·11 cites·4 claims
- 0687US11912723B2KRAS modulators and uses thereofQUANTA THERAPEUTICS INC·Filed 2023·Granted Feb 27, 2024·1 cites·39 claims
- 0786US9346840B2Cyclopropylamines as LSD1 inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2014·Granted May 24, 2016·7 cites·12 claims
- 0886US8846935B2IndazolesDUQUENNE CELINE·Filed 2011·Granted Sep 30, 2014·18 cites·7 claims
- 0984US9073924B2AzaindazolesBURGESS JOELLE LORRAINE·Filed 2012·Granted Jul 7, 2015·5 cites·2 claims
- 1084US8637509B2AzaindazolesBURGESS JOELLE LORRAINE·Filed 2011·Granted Jan 28, 2014·12 cites·6 claims
- 1179US9402836B2IndolesGLAXOSMITHKLINE LLC·Filed 2015·Granted Aug 2, 2016·2 cites·10 claims
- 1279US7884098B2Anthranilamide inhibitors of aurora kinaseGLAXOSMITHKLINE LLC·Filed 2008·Granted Feb 8, 2011·3 cites·3 claims
- 1378US9790212B2Enhancer of zeste homolog 2 inhibitorsGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2016·Granted Oct 17, 2017·2 cites·20 claims
- 1478US7338959B2Diamino-pyrimidines and their use as angiogenesis inhibitorsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Mar 4, 2008·16 cites·33 claims
- 1577US10064854B2Cyclopropylamines as LSD1 inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2017·Granted Sep 4, 2018·1 cites·14 claims
- 1677US9018382B2IndazolesGLAXOSMITHKLINE LLC·Filed 2014·Granted Apr 28, 2015·3 cites·9 claims
- 1774US9795597B2Cyclopropylamines as LSD1 inhibitorsGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2016·Granted Oct 24, 2017·1 cites·6 claims
- 1872US2025243222A1Pyrimidine based modulators and uses thereofQUANTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1971US12145947B2Pyrimidine based modulators and uses thereofQUANTA THERAPEUTICS INC·Filed 2023·Granted Nov 19, 2024·0 cites·22 claims
- 2071US2025042921A1Kras modulators and uses thereofQUANTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2163US9012479B2Pyrazolylaminopyridines as inhibitors of FAKGLAXOSMITHKLINE LLC·Filed 2013·Granted Apr 21, 2015·0 cites·11 claims
- 2261US2011207743A1Pyrazolylaminopyridines as inhibitors of fakADAMS JERRY LEROY·Filed 2009·Application pending·0 cites
- 2361US2010113475A1Pyrazolylaminopyridines as inhibitors of fakADAMS JERRY LEROY·Filed 2009·Application pending·0 cites
- 2458US9446034B2Pyrazolylaminopyridines as inhibitors of FAKGLAXOSMITHKLINE LLC·Filed 2015·Granted Sep 20, 2016·0 cites·2 claims
- 2557US7189745B1CompoundsSMITHKLINE BEECHAM CORP·Filed 2000·Granted Mar 13, 2007·1 cites·15 claims
- 2653US2015265589A1Pyrazolylaminopyridines as inhibitors of fakGLAXOSMITHKLINE LLC·Filed 2015·Application pending·0 cites
- 2751US2007010534A1Novel compoundsSMITHKLINE BEECHAM CORP·Filed 2006·Application pending·0 cites
- 2849US2010311736A1Pyridosulfonamide derivatives as p13 kinase inhibitorsGLAXOSMITHKLINE LLC·Filed 2008·Application pending·0 cites
- 2948US2011269774A1Pyrazolylaminopyridines as inhibitors of fakADAMS JERRY·Filed 2011·Application pending·0 cites
- 3046US2008214455A1Novel Chemical CompoundsSMITHKLINE BEECHAM CORP·Filed 2006·Application pending·0 cites
- 3145US2010317663A1Anilinopyridines as inhibitors of fakADAMS JERRY LEROY·Filed 2009·Application pending·0 cites
- 3243US2009203692A1Novel chemical compoundsSMITHKLINE BEECHAM CORP·Filed 2006·Application pending·0 cites
- 3343US2014155410A1Pyrazolylaminopyridines as inhibitors of fakGLAXOSMITHKLINE LLC·Filed 2014·Application pending·0 cites
- 3442US2007249599A1Novel Chemical CompoundsDUFFY KEVIN J·Filed 2005·Application pending·0 cites
- 3535US2015344968A1Methods for determining parp inhibitor and platinum resistance in cancer therapyINST CANCER RES D B A THE RES INST OF FOX CHASE CANCER CT·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Neil W. Johnson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →